Navigation Links
SuperNova Diagnostics® to Present at Biotech Showcase™ 2012 During JP Morgan Healthcare Conference January 9 - 12
Date:1/3/2012

WASHINGTON, LONDON and HONG KONG, Jan. 3, 2012 /PRNewswire/ -- SuperNova Diagnostics®, Inc., a privately-held global diagnostics company for human and non-human health applications, announced that Neil J. Campbell, President and CEO, will present a corporate and technology overview at Biotech Showcase 2012 in San Francisco, CA.  Mr. Campbell's presentation is scheduled for Monday, January 9, 2012 at 4:45pm in the Stockton Room at the Parc 55 Wyndham Union Square Hotel.

The presentation will include an overview of SuperNova's proprietary point-of-care (POC) and point-of-use (POU) diagnostic technology, targeted for four industry sectors: human health, animal health, industrial and biodefense / biosecurity; as well as provide additional details on the company's recent commercial partnership with Concile, GmbH.

"Biotech Showcase is the premier event for investors and business leaders in the healthcare industry, and is an ideal opportunity for SuperNova to feature its 'lab-in-the-palm-of-your-hand' diagnostic system," said Mr. Campbell.  "With our AmpCrystal® platform, which provides an array of diagnostic capabilities at point of interest settings in human and non-human applications as well as improving central laboratory assays, SuperNova is well poised to capture the multi-billion dollar point-of-care and general diagnostic markets." 

About SuperNova Diagnostics®, Inc.
SuperNova® is a development-stage diagnostics company with a proprietary platform for conducting diagnostics at the site of interest with point-of-care in human health and point-of-use for non-human health applications.  A powerful proprietary nanochemistry, AmpCrystal®, can deliver novel, next generation performance for pathogens, proteins, and directly measure DNA without PCR with ultra-low sensitivity and specificity while not sacrificing a dynamic range of measurements.  SuperNova can be utilized in a wide range of diagnostic formats (lateral flow, self-contained cartridges, microtitre, microarrays, closed systems, research products and OEM). SuperNova® — Putting the Laboratory in the Palm of Your Hand®.  For additional information, please visit www.supernovadiagnostics.com.

Contacts:
Tiberend Strategic Advisors, Inc.
Jason Rando / June Gregg
(212) 827-0020
jrando@tiberend.com / jgregg@tiberend.com


'/>"/>
SOURCE SuperNova Diagnostics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. SuperNova Diagnostics® to Present at the 23rd Annual Piper Jaffray Healthcare Conference in New York City
2. SuperNova Diagnostics® to Present at AdvaMed 2011: The Medtech Conference in Washington, D.C.
3. SuperNova Diagnostics® Selected to Present at Launch: Silicon Valley 2011
4. SuperNova Diagnostics® Announces Agreement with KSB Diagnostics of China to Commercialise Neopterin Diagnostics
5. Quest Diagnostics® Care360™ EHR Receives ONC-ATCB 2011/2012 Certification
6. Amylin Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
7. ShangPharma to Present at J.P. Morgans 30th Annual Healthcare Conference
8. Amgen Presents Final Results from the Largest Phase 3 Open-Label Study Assessing the Safety and Efficacy of Nplate® (Romiplostim)
9. Tengion Presents New Scientific Data in Presentations at TERMIS North America Annual Meeting
10. Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society
11. Sangamo BioSciences Announces Presentation of New Data from ZFP Therapeutic® Program in Hemophilia B at American Society for Hematology Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... Germany and GERMANTOWN, ... QGEN ; Frankfurt Prime Standard: QIA) today announced ... RNA Panels for gene expression profiling, expanding QIAGEN,s portfolio ... The panels enable researchers to select from over 20,000 ... and discover interactions between genes, cellular phenotypes and disease ...
(Date:2/11/2016)... , Feb. 11, 2016  Dovetail Genomics™ LLC ... its beta program for a planned metagenomic genome assembly ... the company,s metagenomic genome assembly method in a talk ... Genome Biology & Technology conference in Orlando, ... these highly complex datasets is difficult. Using its proprietary ...
(Date:2/11/2016)... ... February 11, 2016 , ... Global Stem ... clinic in Quito, Ecuador. The new facility will provide advanced protocols and state-of-the-art ... around the world. , The new GSCG clinic is headed by four ...
(Date:2/10/2016)... 2016 ASAE is introducing a hybrid membership ... (AMC) the option of joining or renewing through an ... by staff size, every employee in any size association ... reap all available member benefits.   John ... membership options will allow organizations of any size and ...
Breaking Biology Technology:
(Date:2/2/2016)... , Feb. 2, 2016 Technology Enhancements Accelerate ... an analysis of the digital and computed radiography markets ... , and Indonesia (TIM). ... and market size, as well as regional market drivers ... and discusses market penetration and market attractiveness, both for ...
(Date:2/1/2016)... -- Rising sales of consumer electronics coupled ... gesture control market size through ... electronics coupled with new technological advancements to drive global ... through 2020   --> Rising ... to drive global touchfree intuitive gesture control market ...
(Date:1/28/2016)... Synaptics (NASDAQ: SYNA ), a leading developer of ... ended December 31, 2015. --> ... increased 2 percent compared to the comparable quarter last year to ... was $35.0 million, or $0.93 per diluted share. ... first quarter of fiscal 2016 grew 9 percent over the prior ...
Breaking Biology News(10 mins):